Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infection mitigation a necessity in lupus patients.

Literature DB >> 30349984

Infection mitigation a necessity in lupus patients.

Peiyun Liu¹, Hui Zhuan Tan², Huihua Li³, Jason Chon Jun Choo², Cynthia Ciwei Lim².

Abstract

Entities: Disease Species

Mesh：

Year: 2018 PMID： 30349984 DOI： 10.1007/s10067-018-4346-1

Source DB: PubMed Journal: Clin Rheumatol ISSN： 0770-3198 Impact factor: 2.980

Keyword Cloud
References

× No keyword cloud information.

10 in total

Review 1. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality.

Authors: Rupert W Jakes; Sang-Cheol Bae; Worawit Louthrenoo; Chi-Chiu Mok; Sandra V Navarra; Namhee Kwon
Journal: Arthritis Care Res (Hoboken) Date: 2012-02 Impact factor: 4.794

2. Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy.

Authors: Cynthia C Lim; Yu Tzu Tung; Ban Hock Tan; Puay Hoon Lee; Irene Mok; Lynette Oon; Kwai Peng Chan; Jason Cj Choo
Journal: Nephrology (Carlton) Date: 2018-07 Impact factor: 2.506

3. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality.

Authors: C L Teh; S A Wan; G R Ling
Journal: Clin Rheumatol Date: 2018-04-18 Impact factor: 2.980

4. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.

Authors: Marie B Condon; Damien Ashby; Ruth J Pepper; H Terence Cook; Jeremy B Levy; Megan Griffith; Tom D Cairns; Liz Lightstone
Journal: Ann Rheum Dis Date: 2013-06-05 Impact factor: 19.103

Infection mitigation a necessity in lupus patients.

Review 1. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality.

2. Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy.

3. Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality.

4. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.

5. Survival analysis and causes of mortality in patients with lupus nephritis.

6. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.

Review 7. The role of the immune system in kidney disease.

Review 8. Can we manage lupus nephritis without chronic corticosteroids administration?

9. Infections in hospitalized lupus nephritis patients: characteristics, risk factors, and outcomes.

Review 10. How can we reduce the risk of serious infection for patients with systemic lupus erythematosus?